Developer docs
API playgroundTry for free, no card

Search company profiles

Enze Kangtai

Full company profile

uuid00213yw

Namestring
Enze Kangtai
Legal namestring
Enze Kangtai
Websiteurl
echobiotech.com
Company typeenum
Private
Founded yearint
2017
Short descriptiontext

Enze Kangtai (Echo Biotech) is a Beijing-based biotech firm that develops and manufactures exosome-based products and services spanning research reagents, GMP raw materials, and CDMO solutions for research institutions, hospitals, and biotech enterprises in China.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersChangping, China
HQ citystring
Changping
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
exosome research reagents, GMP exosome manufacturing, engineered exosome products, exosome isolation kits, exosome multi-omics services
Industry3 codes
1Biologics (mAbs/Recombinant Proteins) CDMO
CodeHLAGABACPrimaryYes
2Bioprocess Consumables & Reagents (resins, membranes, media components, buffers)
CodeHLAAAJAIPrimaryNo
3Proteomics & Biomarker Analytical Testing
CodeHLAGADAGPrimaryNo
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Services-Commercial Physical & Biological Research8731
Product category
Exosome Biotechnology
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1GMP Exosome Raw Materials Sales
TypeOne Time License
Description

Sale of GMP-grade stem cell exosomes and engineered exosome materials for regenerative medicine research and drug development. Products include GoldenExo® NFSA, NPNR, NCLU, NCSK, NCBA, NATX, and engineered exosomes for HAIR and SKIN applications.

echobiotech.com
2Exosome Research Reagents
TypeOne Time License
Description

Sale of exosome purification kits (Exosupur®), engineering modification kits (ExoLoad®, ExoBrooch®, ExoCoupl®), detection/identification kits (ExosuperQC®), cell culture and tracing reagents (FluoExo®, ExoCCM®).

echobiotech.com
3Exosome Research Services
TypeProfessional Services
Description

Services including exosome omics research, quality analytics/testing, and advanced exosome technologies/solutions. Covers exosome multi-omics profiling, quality analysis, and CDMO services for GMP-grade stem cell exosome raw materials supporting drug filing requirements.

echobiotech.com
4Exosome Finished Products
TypeOne Time License
Description

Research-use exosome finished products including ContrExo 293F Exosome Reference Product, ContrExo 293F Exosome Standard Product, ContrExo High-Concentration HuMSC Exosomes, and ContrExo High-Purity HuMSC Exosomes.

echobiotech.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1GoldenExo®
Description

GMP-grade stem cell exosome raw material product line covering multiple directions including NFSA (systemic anti-inflammatory), NPNR (neural repair), NCLU (respiratory system), NCSK (skin repair), NCBA (basic stem cell), and NATX (customized premium solution).

echobiotech.com
+8 more records
Core offering1 text field

Echo Biotech develops and manufactures exosome-based biotechnology products, including GMP-grade stem cell and engineered exosome raw materials, exosome isolation/purification kits, engineering modification kits, detection kits, cell culture reagents, and exosome tracing dyes. The company also provides exosome multi-omics research services, quality analytics/testing, and CDMO services for GMP-grade exosome raw materials supporting drug filing requirements.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Up to 95% particle recovery rate with Exosupur® SEC purification kits
+4 more records
Product overview1 text field

Echo biotech is an innovative high-tech company delivering end-to-end solutions for exosome regenerative therapies and systemic anti-aging programs. The company operates across three integrated platforms: Exoomics® (exosome multi-omics analysis), Echosome® (engineered exosome platform), and EchoPharm® (large-scale GMP manufacturing). The product portfolio includes GMP-grade exosome raw materials under the GoldenExo® brand (NFSA, NPNR, NCLU, NCSK, NCBA, NATX for stem cell exosomes, plus HAIR and SKIN engineered exosomes), research-use exosome finished products (ContrExo series), comprehensive exosome isolation and purification solutions under the Exosupur® brand (SEC columns, concentration kits, tissue isolation kits, rapid purification kits, mini columns), exosome engineering modification kits (ExoLoad®, ExoBrooch®, ExoCoupl®), detection and characterization tools (ExosuperQC® WB kits), and cell culture/tracing reagents (ExoCCM® depleted serum, FluoExo® tracing dye kits). The company also provides CDMO services for GMP-grade exosome raw materials supporting drug filing requirements.

Product and service1 record
1GoldenExo® NFSA GMP Stem Cell Exosome Raw Material
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Evox Therapeutics
TypeDirect peer
Description

UK-based biotech engineering exosomes for therapeutic delivery of nucleic acids and protein drugs. Comparable to Echo Biotech's Echosome® engineered exosome platform and ExoLoad® nucleic acid loading technology for therapeutic applications.

2Lonza Group
TypeBroad incumbent
Description

Swiss-headquartered global CDMO leader in biologics, cell and gene therapies, and novel modalities including mRNA. Comparable as a broad incumbent GMP manufacturer that could compete with Echo Biotech's CDMO services and is expanding into exosome and extracellular vesicle manufacturing.

3System Biosciences (SBI)
TypeDirect peer
Description

SBI is a U.S.-based developer of exosome research tools and reagents including isolation kits, engineered exosomes, and exosome standards. Directly comparable to Echo Biotech's Exosupur®, ExoLoad®, and ContrExo® product lines in serving exosome researchers with kits and standards.

4Sartorius
TypeBroad incumbent
Description

German-headquartered bioprocessing equipment and consumables supplier for cell and gene therapy, biologics, and advanced therapy manufacturing. Comparable to Echo Biotech on the bioprocess infrastructure side and as a potential incumbent expanding into exosome manufacturing workflows.

5Capricor Therapeutics
TypeDirect peer
Description

U.S. clinical-stage biotech developing exosome-based therapeutics (CAP-1002, CAP-2003) for inflammatory and rare diseases. Comparable as a peer in translating extracellular vesicle biology into clinical-stage regenerative medicine products.

6Genscript
TypeDirect peer
Description

China/U.S.-based biotech providing gene synthesis, protein production, and life science research services and reagents. Comparable to Echo Biotech on serving the Chinese life science research market with research tools, custom services, and biologics-related offerings.

7Bio-Techne
TypeBroad incumbent
Description

U.S.-based global life science reagent and tools company with proteins, antibodies, kits, and analytical platforms used in cell and gene therapy research. Comparable to Echo Biotech's research reagent catalog and serves overlapping academic and biopharma researcher customer base.

8Wuxi AppTec
TypeRegional player
Description

China-based global CRO/CDMO offering biologics manufacturing, cell and gene therapy services, and bioanalytical testing. Comparable to Echo Biotech's EchoPharm® GMP exosome manufacturing platform and analytical services, particularly for China-domiciled biotech customers.

9Hansabiomed Life Sciences
TypeDirect peer
Description

Estonian-based supplier of extracellular vesicle isolation kits, characterization tools, and reference materials. Comparable to Echo Biotech on exosome purification kits, QC standards, and reference products targeting academic and biopharma researchers.

10Cytiva (Danaher)
TypeBroad incumbent
Description

Global life science tools and bioprocessing supplier offering filtration, chromatography, cell culture media, and biomanufacturing systems used in bioprocess workflows. Comparable as a supplier of technologies underpinning exosome purification (TFF, chromatography) that compete with Echo Biotech's kit and reagent offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Enze Kangtai

Exosome Biotechnologyechobiotech.com

Enze Kangtai (Echo Biotech) is a Beijing-based biotech firm that develops and manufactures exosome-based products and services spanning research reagents, GMP raw materials, and CDMO solutions for research institutions, hospitals, and biotech enterprises in China.

Enze Kangtai firmographics

Firmographics
Name
Enze Kangtai
Legal name
Enze Kangtai
Website
https://echobiotech.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
101–250 employees
Short description
Enze Kangtai (Echo Biotech) is a Beijing-based biotech firm that develops and manufactures exosome-based products and services spanning research reagents, GMP raw materials, and CDMO solutions for research institutions, hospitals, and biotech enterprises in China.
Ownership category
akta.pro rank

Enze Kangtai industry classification

Industry
Product category
Exosome Biotechnology
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Biological Products, (No Disgnostic Substances) (2836), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC)
akta.pro secondary industries
Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI), Proteomics & Biomarker Analytical Testing (HLAGADAG)

Keywords

  • Exosome research reagents
  • GMP exosome manufacturing
  • Engineered exosome products
  • Exosome isolation kits
  • Exosome multi-omics services

Where Enze Kangtai is headquartered

Location

Headquarters

HQ city
Changping
HQ country
China
HQ region
Asia

Offices1 record

Markets served

Enze Kangtai business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. GMP Exosome Raw Materials Sales: Sale of GMP-grade stem cell exosomes and engineered exosome materials for regenerative medicine research and drug development. Products include GoldenExo® NFSA, NPNR, NCLU, NCSK, NCBA, NATX, and engineered exosomes for HAIR and SKIN applications.
  2. Exosome Research Reagents: Sale of exosome purification kits (Exosupur®), engineering modification kits (ExoLoad®, ExoBrooch®, ExoCoupl®), detection/identification kits (ExosuperQC®), cell culture and tracing reagents (FluoExo®, ExoCCM®).
  3. Exosome Research Services: Services including exosome omics research, quality analytics/testing, and advanced exosome technologies/solutions. Covers exosome multi-omics profiling, quality analysis, and CDMO services for GMP-grade stem cell exosome raw materials supporting drug filing requirements.
  4. Exosome Finished Products: Research-use exosome finished products including ContrExo 293F Exosome Reference Product, ContrExo 293F Exosome Standard Product, ContrExo High-Concentration HuMSC Exosomes, and ContrExo High-Purity HuMSC Exosomes.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Enze Kangtai product offering

Product offering

Core offering

Echo Biotech develops and manufactures exosome-based biotechnology products, including GMP-grade stem cell and engineered exosome raw materials, exosome isolation/purification kits, engineering modification kits, detection kits, cell culture reagents, and exosome tracing dyes. The company also provides exosome multi-omics research services, quality analytics/testing, and CDMO services for GMP-grade exosome raw materials supporting drug filing requirements.

Product overview

Echo biotech is an innovative high-tech company delivering end-to-end solutions for exosome regenerative therapies and systemic anti-aging programs. The company operates across three integrated platforms: Exoomics® (exosome multi-omics analysis), Echosome® (engineered exosome platform), and EchoPharm® (large-scale GMP manufacturing). The product portfolio includes GMP-grade exosome raw materials under the GoldenExo® brand (NFSA, NPNR, NCLU, NCSK, NCBA, NATX for stem cell exosomes, plus HAIR and SKIN engineered exosomes), research-use exosome finished products (ContrExo series), comprehensive exosome isolation and purification solutions under the Exosupur® brand (SEC columns, concentration kits, tissue isolation kits, rapid purification kits, mini columns), exosome engineering modification kits (ExoLoad®, ExoBrooch®, ExoCoupl®), detection and characterization tools (ExosuperQC® WB kits), and cell culture/tracing reagents (ExoCCM® depleted serum, FluoExo® tracing dye kits). The company also provides CDMO services for GMP-grade exosome raw materials supporting drug filing requirements.

Differentiator

Problem solved

Functional benefit

Brands

  • GoldenExo®: GMP-grade stem cell exosome raw material product line covering multiple directions including NFSA (systemic anti-inflammatory), NPNR (neural repair), NCLU (respiratory system), NCSK (skin repair), NCBA (basic stem cell), and NATX (customized premium solution).
  • Exosupur®
  • ExoLoad®
  • ExoBrooch®
  • ExoCoupl®
  • ContrExo®
  • FluoExo®
  • ExosuperQC®
  • ExoCCM®

Products and services

  • GoldenExo® NFSA GMP Stem Cell Exosome Raw Material

Quantifiable outcome

  • Up to 95% particle recovery rate with Exosupur® SEC purification kits
  • +4 more outcomes

Companies that use Enze Kangtai

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Enze Kangtai technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Enze Kangtai partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Enze Kangtai competitors and assessment

Company assessment

Direct peers

  • Evox Therapeutics: UK-based biotech engineering exosomes for therapeutic delivery of nucleic acids and protein drugs. Comparable to Echo Biotech's Echosome® engineered exosome platform and ExoLoad® nucleic acid loading technology for therapeutic applications.
  • System Biosciences (SBI): SBI is a U.S.-based developer of exosome research tools and reagents including isolation kits, engineered exosomes, and exosome standards. Directly comparable to Echo Biotech's Exosupur®, ExoLoad®, and ContrExo® product lines in serving exosome researchers with kits and standards.
  • Capricor Therapeutics: U.S. clinical-stage biotech developing exosome-based therapeutics (CAP-1002, CAP-2003) for inflammatory and rare diseases. Comparable as a peer in translating extracellular vesicle biology into clinical-stage regenerative medicine products.
  • Genscript: China/U.S.-based biotech providing gene synthesis, protein production, and life science research services and reagents. Comparable to Echo Biotech on serving the Chinese life science research market with research tools, custom services, and biologics-related offerings.
  • Hansabiomed Life Sciences: Estonian-based supplier of extracellular vesicle isolation kits, characterization tools, and reference materials. Comparable to Echo Biotech on exosome purification kits, QC standards, and reference products targeting academic and biopharma researchers.

Broad incumbents

  • Lonza Group: Swiss-headquartered global CDMO leader in biologics, cell and gene therapies, and novel modalities including mRNA. Comparable as a broad incumbent GMP manufacturer that could compete with Echo Biotech's CDMO services and is expanding into exosome and extracellular vesicle manufacturing.
  • Sartorius: German-headquartered bioprocessing equipment and consumables supplier for cell and gene therapy, biologics, and advanced therapy manufacturing. Comparable to Echo Biotech on the bioprocess infrastructure side and as a potential incumbent expanding into exosome manufacturing workflows.
  • Bio-Techne: U.S.-based global life science reagent and tools company with proteins, antibodies, kits, and analytical platforms used in cell and gene therapy research. Comparable to Echo Biotech's research reagent catalog and serves overlapping academic and biopharma researcher customer base.
  • Cytiva (Danaher): Global life science tools and bioprocessing supplier offering filtration, chromatography, cell culture media, and biomanufacturing systems used in bioprocess workflows. Comparable as a supplier of technologies underpinning exosome purification (TFF, chromatography) that compete with Echo Biotech's kit and reagent offerings.

Regional players

  • Wuxi AppTec: China-based global CRO/CDMO offering biologics manufacturing, cell and gene therapy services, and bioanalytical testing. Comparable to Echo Biotech's EchoPharm® GMP exosome manufacturing platform and analytical services, particularly for China-domiciled biotech customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Enze Kangtai compliance and trust

Trust signal

Compliance3 records

Enze Kangtai financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Enze Kangtai leadership team

Management profile

Number of profiles

Enze Kangtai funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Enze Kangtai M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Enze Kangtai

What does Enze Kangtai do?

Echo Biotech develops and manufactures exosome-based biotechnology products, including GMP-grade stem cell and engineered exosome raw materials, exosome isolation/purification kits, engineering modification kits, detection kits, cell culture reagents, and exosome tracing dyes. The company also provides exosome multi-omics research services, quality analytics/testing, and CDMO services for GMP-grade exosome raw materials supporting drug filing requirements.

Is Enze Kangtai a public or private company?

Enze Kangtai is a private company. It is classified as venture growth investor backed and is currently operating.

When was Enze Kangtai founded?

Enze Kangtai was founded in 2017. It employs 101 to 250 people.

Where is Enze Kangtai based?

Enze Kangtai is headquartered in Changping, China, in the Asia region.

How does Enze Kangtai make money?

Four revenue lines are on record. GMP Exosome Raw Materials Sales are the primary driver. The others are exosome Research Reagents, exosome Research Services and exosome Finished Products.

Who are Enze Kangtai's main competitors?

Direct peers on record are Evox Therapeutics, System Biosciences (SBI), Capricor Therapeutics, Genscript and Hansabiomed Life Sciences. Broad incumbents are Lonza Group, Sartorius, Bio-Techne and Cytiva (Danaher). Wuxi AppTec is listed as a regional player.

Does Enze Kangtai have an API?

No public API is recorded for Enze Kangtai.

What industry is Enze Kangtai in?

Enze Kangtai's product category is Exosome Biotechnology. Its primary akta.pro industry code is HLAGABAC, Biologics (mAbs/Recombinant Proteins) CDMO, with a secondary code of HLAAAJAI, Bioprocess Consumables & Reagents (resins, membranes, media components, buffers). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales